Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug.
from Latest Science News -- ScienceDaily https://ift.tt/8sfqijQ
No comments:
Post a Comment